Show threadFaraiweFeb 25, 2025

Russell #Vought is one of the main authors of #Project2025, the #nazi movement guidebook for MAGAts.

His daughter suffers from #CysticFibrosis.

She was treated by a drug, #Trikafta, developed by Vertex Pharmaceutic, under a grant by the National Institute of Health, US/DoH/NIH.

Project2025 is dismantling the #NIH.

But it's ok. Vought already got what he needed.

https://www.motherjones.com/politics/2025/02/project-2025-vought-medical-funding/

MAGAts are NOT human, have no souls, can not be saved, are burnt meat.

2/2

#TurdReich

Project 2025 is gutting medical funding that helped Russell Vought's own kid

Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.

Mother Jones
Global NewsNov 23, 2024
Saskatchewan expands Trikafta coverage for cystic fibrosis
The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.
#globalnews #Health #CysticFibrosis #SaskatchewanHealthAuthority #Trikafta
https://globalnews.ca/news/10884439/saskatchewan-expands-trikafta-coverage-cystic-fibrosis/
Saskatchewan expands Trikafta coverage for cystic fibrosis

The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.

Global News
Global News ReginaNov 22, 2024
Saskatchewan expands Trikafta coverage for cystic fibrosis
The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.
#globalnews #Health #CysticFibrosis #SaskatchewanHealthAuthority #Trikafta
https://globalnews.ca/news/10884439/saskatchewan-expands-trikafta-coverage-cystic-fibrosis/
Saskatchewan expands Trikafta coverage for cystic fibrosis

The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.

Global News
Global News SaskatoonNov 22, 2024
Saskatchewan expands Trikafta coverage for cystic fibrosis
The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.
#globalnews #Health #CysticFibrosis #SaskatchewanHealthAuthority #Trikafta
https://globalnews.ca/news/10884439/saskatchewan-expands-trikafta-coverage-cystic-fibrosis/
Saskatchewan expands Trikafta coverage for cystic fibrosis

The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.

Global News
🌈 Kevin Bowersox 🖖 Nov 11, 2024
- Trikafta is a miracle drug for CF that is currently keeping my son alive.
- Trikafte costs ~$5.8K to make a year's supply.
- Vertex, the maker of Trikafta, charges $322K for a year's supply.
- Vertex is also actively working to prevent a generic from being made.
- Vertex are assholes. Real scum.

#medicine #CysticFibrosis #Healthcare #Trikafta
Global NewsDec 14, 2023
Alberta further expands access of revolutionary cystic fibrosis drug Trikafta to young kids
Trikafta is a breakthrough prescription drug: rather than just treating symptoms of cystic fibrosis, it targets the basic defect from one specific genetic mutation that causes CF.
#globalnews #Health #Albertahealth #CysticFibrosis #Trikafta
https://globalnews.ca/news/10168887/alberta-cystic-fibrosis-trikafta-children/
Alberta further expands access of revolutionary cystic fibrosis drug Trikafta to young kids

Trikafta is a breakthrough prescription drug: rather than just treating symptoms of cystic fibrosis, it targets the basic defect from one specific genetic mutation that causes CF.

Global News
Global News EdmontonDec 14, 2023
Alberta further expands access of revolutionary cystic fibrosis drug Trikafta to young kids
Trikafta is a breakthrough prescription drug: rather than just treating symptoms of cystic fibrosis, it targets the basic defect from one specific genetic mutation that causes CF.
#globalnews #Health #Albertahealth #CysticFibrosis #Trikafta
https://globalnews.ca/news/10168887/alberta-cystic-fibrosis-trikafta-children/
Alberta further expands access of revolutionary cystic fibrosis drug Trikafta to young kids

Trikafta is a breakthrough prescription drug: rather than just treating symptoms of cystic fibrosis, it targets the basic defect from one specific genetic mutation that causes CF.

Global News
Global News CalgaryDec 14, 2023
Alberta further expands access of revolutionary cystic fibrosis drug Trikafta to young kids
Trikafta is a breakthrough prescription drug: rather than just treating symptoms of cystic fibrosis, it targets the basic defect from one specific genetic mutation that causes CF.
#globalnews #Health #Albertahealth #CysticFibrosis #Trikafta
https://globalnews.ca/news/10168887/alberta-cystic-fibrosis-trikafta-children/
Alberta further expands access of revolutionary cystic fibrosis drug Trikafta to young kids

Trikafta is a breakthrough prescription drug: rather than just treating symptoms of cystic fibrosis, it targets the basic defect from one specific genetic mutation that causes CF.

Global News
Victoria Stuart 🇨🇦 🏳️‍⚧️Sep 17, 2023

Life-changing cystic fibrosis treatment wins US$3-million Breakthrough Prize
https://www.nature.com/articles/d41586-023-02890-1
Discussion: https://news.ycombinator.com/item?id=37535537

* triple-drug combination Trikafta helps 90% of people w. cystic fibrosis
* inherited disorder affecting lungs, other organs
* mutations in gene that makes the cystic fibrosis transmembrane conductance regulator protein (CFTR)
* involved in production of mucus, sweat, other fluids

#CysticFibrosis #Trikafta #disease #medicine #BreakthroughPrize #CFTR

Life-changing cystic fibrosis treatment wins US$3-million Breakthrough Prize

Trio of chemists who developed the combination drug Trikafta are among the winners of five major awards in life sciences, physics and mathematics.

Joyce Bell 🇺🇦🇨🇦🇲🇽🇬🇱🚫🧊Apr 26, 2023
Great news for young kids with Cystic Fibrosis aka CF. FDA approves Trikafta use for 2-5 year olds with certain mutations. https://www.cff.org/news/2023-04/trikafta-approval-ages-2-5-mutations #CysticFibrosis #CF #Trikafta
FDA Approves Trikafta for Children Ages 2 Through 5 Years With Certain CF Mutations

With this approval, approximately 2,250 children in the U.S. will be eligible for Trikafta® (elexacaftor/tezacaftor/ivacaftor), including more than 900 who will have access to a CFTR modulator for the first time. The Cystic Fibrosis Foundation believes it is beneficial to start people with cystic fibrosis on modulators as early as possible to help prevent lung damage and the onset of complications.

Cystic Fibrosis Foundation